News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,687 Results
Type
Article (41452)
Company Profile (264)
Press Release (690959)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (204922)
Career Advice (2033)
Deals (35617)
Drug Delivery (131)
Drug Development (81559)
Employer Resources (173)
FDA (16520)
Job Trends (15000)
News (346982)
Policy (32754)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2603)
Accelerated approval (53)
Adcomms (27)
Allergies (176)
Alliances (49589)
ALS (216)
Alzheimer's disease (1810)
Antibody-drug conjugate (ADC) (486)
Approvals (16938)
Artificial intelligence (687)
Autoimmune disease (315)
Automation (58)
Bankruptcy (362)
Best Places to Work (11640)
BIOSECURE Act (20)
Biosimilars (225)
Biotechnology (171)
Bladder cancer (200)
Brain cancer (73)
Breast cancer (783)
Cancer (6086)
Cardiovascular disease (485)
Career advice (1728)
Career pathing (44)
CAR-T (344)
CDC (57)
Celiac Disease (3)
Cell therapy (929)
Cervical cancer (51)
Clinical research (71159)
Collaboration (2116)
Company closure (5)
Compensation (1437)
Complete response letters (82)
COVID-19 (2749)
CRISPR (111)
C-suite (1168)
Cystic fibrosis (154)
Data (8293)
Decentralized trials (3)
Denatured (28)
Depression (163)
Dermatology (93)
Diabetes (609)
Diagnostics (6981)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (332)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (292)
Earnings (92174)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (120159)
Executive appointments (1097)
FDA (20354)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1769)
Gene editing (238)
Generative AI (58)
Gene therapy (732)
GLP-1 (1062)
Government (4739)
Grass and pollen (6)
Guidances (414)
Healthcare (19119)
HIV (82)
Huntington's disease (57)
IgA nephropathy (106)
Immunology and inflammation (291)
Immuno-oncology (98)
Indications (200)
Infectious disease (3102)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (300)
Interviews (320)
IPO (16678)
IRA (50)
Job creations (3653)
Job search strategy (1431)
JPM (58)
Kidney cancer (20)
Labor market (106)
Layoffs (567)
Leadership (40)
Legal (7954)
Liver cancer (102)
Longevity (33)
Lung cancer (814)
Lymphoma (446)
Machine learning (60)
Management (59)
Manufacturing (1084)
MASH (200)
Medical device (13954)
Medtech (14092)
Mergers & acquisitions (20202)
Metabolic disorders (1550)
mRNA (217)
Multiple sclerosis (193)
NASH (17)
Neurodegenerative disease (434)
Neuropsychiatric disorders (106)
Neuroscience (3370)
Neurotech (1)
NextGen: Class of 2026 (6524)
Non-profit (4533)
Now hiring (79)
Obesity (719)
Opinion (289)
Ovarian cancer (233)
Pain (258)
Pancreatic cancer (326)
Parkinson's disease (376)
Partnered (33)
Patents (610)
Patient recruitment (696)
Peanut (64)
People (59721)
Pharmaceutical (58)
Pharmacy benefit managers (33)
Phase 1 (22189)
Phase 2 (31351)
Phase 3 (23324)
Pipeline (9258)
Policy (322)
Postmarket research (2569)
Preclinical (9434)
Press Release (64)
Prostate cancer (322)
Psychedelics (54)
Radiopharmaceuticals (337)
Rare diseases (1102)
Real estate (5985)
Recruiting (70)
Regulatory (25562)
Reports (56)
Research institute (2417)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (179)
Series A (297)
Series B (217)
Service/supplier (11)
Sickle cell disease (116)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3647)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (87)
The Weekly (64)
Vaccines (1119)
Venture capital (114)
Weight loss (459)
Women's health (129)
Worklife (20)
Date
Today (112)
Last 7 days (762)
Last 30 days (3430)
Last 365 days (30266)
2026 (14269)
2025 (30171)
2024 (35210)
2023 (40082)
2022 (51182)
2021 (55712)
2020 (54087)
2019 (46539)
2018 (35017)
2017 (32107)
2016 (31484)
2015 (37571)
2014 (31325)
2013 (26357)
2012 (28578)
2011 (29279)
2010 (27346)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (354)
Arkansas (14)
Asia (39896)
Australia (6527)
California (13643)
Canada (3851)
China (1413)
Colorado (580)
Connecticut (596)
Delaware (420)
Europe (86136)
Florida (2036)
Georgia (438)
Hawaii (3)
Idaho (63)
Illinois (1099)
India (92)
Indiana (617)
Iowa (23)
Japan (559)
Kansas (132)
Kentucky (50)
Louisiana (44)
Maine (76)
Maryland (1629)
Massachusetts (9744)
Michigan (370)
Minnesota (737)
Mississippi (6)
Missouri (146)
Montana (33)
Nebraska (29)
Nevada (145)
New Hampshire (84)
New Jersey (3570)
New Mexico (30)
New York (3569)
North Carolina (1722)
North Dakota (9)
Northern California (6867)
Ohio (408)
Oklahoma (23)
Oregon (41)
Pennsylvania (2735)
Puerto Rico (29)
Rhode Island (51)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5396)
Tennessee (216)
Texas (2168)
United States (48059)
Utah (405)
Vermont (1)
Virginia (328)
Washington D.C. (81)
Washington State (1088)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
732,687 Results for "pharmatech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmatech Associates, a USP Company, appoints Erika Porcelli as Chief Executive Officer
April 27, 2026
·
2 min read
Press Releases
D&D Pharmatech Announces Positive 48-Week Histology Results for Zabopegdutide (DD01), Demonstrating Statistically Significant Fibrosis Improvement and MASH Resolution
May 27, 2026
·
6 min read
Press Releases
Wilmington PharmaTech Launches $50 Million Expansion to Double U.S. Small-Molecule API Manufacturing Capacity in Delaware
March 24, 2026
·
2 min read
Press Releases
Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth
January 12, 2026
·
3 min read
Press Releases
Wilmington PharmaTech Appoints Industry Veteran Kent Payne as Managing Director and Board Member
October 28, 2025
·
4 min read
Press Releases
Quest PharmaTech Provides Corporate Update
June 3, 2025
·
3 min read
Biotech Bay
YDS Pharmatech, Inc. CEO to Highlight AI Advancements in Designing New Drug Modalities at Bio Investor Forum on October 17th
YDS Pharmatech, Inc., a pioneering innovator at a transformative juncture in applying AI to drug discovery, announces its participation in this year’s Bio Investor Forum.
October 16, 2023
·
2 min read
Press Releases
Neuraly, Inc. Supports Phase 2 Investigator-Initiated Trial of Pegsebrenatide (NLY01) for Progressive Multiple Sclerosis
May 5, 2026
·
3 min read
Policy
D&D Pharmatech Granted Fast Track Designation from US FDA for DD01 for the Treatment of NASH/MASH
D&D Pharmatech, Inc., a clinical-stage biotechnology company focused on the development of disease-modifying drugs, announced that the U.S. Food and Drug Administration has granted Fast Track designation for the investigation of DD01 for the treatment of adults with non-alcoholic steatohepatitis, also known as metabolic dysfunction-associated steatohepatitis.
April 2, 2024
·
3 min read
Business
Pharmatech Associates Adds Biotech Leader Praveen Tyle, Ph.D. to Board of Trustees
Pharmatech Associates, a subsidiary of the United States Pharmacopeia, announced it has appointed the biotech expert Dr. Praveen Tyle to its board of trustees.
January 16, 2024
·
2 min read
1 of 73,269
Next
